FDA panel votes against Pfizer booster for general public – CNET

Paradmin

FDA panel votes against Pfizer booster for general public – CNET

In a follow-up vote, the panel voted that the benefits of a third dose for older adults and individuals at high risk of severe COVID-19 outweigh the risks.

À propos de l’auteur

admin administrator